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Abstract
Microneme proteins are secreted from apicomplexan parasites during invasion of host cells and they play crucial roles in parasite–host cell
adhesion. EtMIC4 is a 240 kDa transmembrane protein from Eimeria tenella that contains 31 tandemly arranged epidermal growth factor
(EGF), like repeats within its extracellular domain. The majority of these repeats have calcium binding (cb) consensus sequences. Little is
known about cbEGFs in apicomplexan parasites but their presence in microneme proteins suggests that they may contribute to parasite–host
interactions. To investigate the potential role of cbEGFs we have expressed and correctly refolded a cbEGF triplet from EtMIC4 (cbEGF7–9) and
demonstrated that this triplet binds calcium. Circular dichroism spectroscopic analysis of cbEGF7–9 demonstrates that the molecule undergoes
a gradual change in conformation with increasing levels of calcium. In the presence of calcium, the triplet becomes resistant to proteolytic
degradation by a variety of proteases, a characteristic feature of cbEGF repeats from higher eukaryotic proteins, such as fibrillin, suggesting
that calcium binding induces the formation of a rigid conformation. Moreover, mass spectrometric mapping of the cleavage sites that are
protected by calcium shows that these sites are located both close to and distant from the calcium binding sites, indicating that protection
is not due to steric hindrance by calcium ions, but rather due to the overall conformation adopted by the triplet in the presence of calcium.
Thus, the tandemly-arranged cbEGF repeats within EtMIC4 provide a mechanism whereby, in the calcium-rich extracellular environment,
the molecule could adopt a protease-resistant, rigid structure that could favour its interaction with host cell ligands.
© 2005 Elsevier B.V. All rights reserved.
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1. Introduction
Eimeria tenella is an intracellular protozoan parasite that
belongs to the phylum Apicomplexa, a large group of organ-
isms that cause important diseases of medical and veterinary
importance, such as malaria, toxoplasmosis, neosporosis,
cryptosporidiosis and, for Eimeria species, coccidiosis. Api-
complexan parasites share a mechanism of invasion that is
linked to their unique form of locomotion, gliding motil-
ity, and is dependent on the sequential secretion of mate-
Abbreviations: EtMIC4, Eimeria tenella microneme protein 4; cbEGF,
calcium binding epidermal growth factor like domain
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rial from specialised secretory organelles called micronemes
and rhoptries [1]. Micronemes store collections of soluble
and transmembrane proteins that are secreted from the apical
end of the parasite onto the parasite surface, where they inter-
act with host cell ligands [2]. The energy required for invasion
is provided by an actin–myosin motor that lies just under the
parasite plasma membrane and which is linked to the par-
asite surface through dynamic multi-protein complexes that
include the C-terminal domains of the surface-bound trans-
membrane microneme proteins [3,4].
Several apicomplexan microneme proteins have been
described that contain sequences with homology to epidermal
growth factor (EGF)-like domains. A small number of these
contain specialised EGFs that are predicted to bind calcium
ions. These domains share low overall amino acid homol-
0166-6851/$ – see front matter © 2005 Elsevier B.V. All rights reserved.
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Fig. 1. Structure of cbEGF7–9. (A) Amino acid sequence. For each cbEGF, cysteine residues involved in disulphide bond formation are embolded, and the
canonical calcium binding consensus sequences are highlighted in red. Residues for hydrophobic packing of cbEGF pairs are highlighted in magenta. (B)
Overall domain structure of EtMIC4.
ogy but maintain the classical EGF pattern of six cysteine
residues together with a short calcium binding (cb) consensus
sequence (D/N)-X-(D/N)-E/Q-Xm(D/N*)Xn(Y/F), where m
and n are variable and the asterisk indicates possible -
hydroxylation [5]. EGF-like repeats are widely distributed in
nature and cbEGFs within extracellular proteins are involved
in mediating protein–protein and protein–carbohydrate bind-
ing interactions [6]. They are also structurally important in
functionally diverse processes, such as maintenance of extra-
cellular matrix architecture, blood coagulation and choles-
terol uptake [7].
Although cbEGF domains are present in a number of
secreted, microneme proteins, little is known about the func-
tion of these domains and their calcium binding activity in
the biology and disease processes of apicomplexan parasites.
In this study, we have expressed and purified a prototypical
cbEGF triplet (Fig. 1) from the E. tenella EtMIC4 protein, a
240 kDa multi-modular, transmembrane protein that contains
31 tandemly arrayed EGFs [8]. We have used the recombi-
nant protein to investigate the calcium binding properties of
this cbEGF triplet, which gives an insight into the likely func-
tional role of cbEGFs within EtMIC4 and other apicomplexan
microneme proteins.
2. Experimental procedures
2.1. Materials
Unless otherwise stated, all chemicals and reagents were
purchased from Sigma. The E. coli strain NMR554, trans-
formed by plasmid pRep4 has been described previously
[9].
2.2. Cloning and expression of cbEGF7–9
The coding sequences for cbEGF7–9 (amino acids
300–429) were PCR-amplified from plasmid pFT1 [8] using
Pfu polymerase and oligonucleotide primers EGFfw7–9 (5′-
TAGTAGGGATCCATAGAAGGACGATCAGCAGTGGA-
TATCGACGAGTGCTCCAAG-3′), which incorporates a
Bam HI site (underlined), factor Xa cleavage site (double
underlined) and two spacer amino acids (A, V) upstream
of the start of the cbEGF7 sequence; and EGFrv7–9 (5′-
TAGTAGAAGCTTCTATTAACTGCACACCTTTCCGTC-
GCC-3′), which incorporates a Hind III site (underlined) and
two stop codons downstream of the cbEGF9 sequence. The
authenticity of the amplified product was confirmed by DNA
sequencing and it was ligated into plasmid expression vector
pQ30 (Qiagen) in frame with the N-terminal (His)6 tag.
Recombinant plasmid pEGF7–9pQ30 was transformed into
E. coli NMR554 [10], which contains the lac repressor on
plasmid pRep4. Bacteria were grown at 37 ◦C with shaking
in 2 l of 2xTY medium containing 25g ml−1 kanamycin
and 100g ml−1 ampicillin until reaching an OD A600 of
0.8 as determined by UV spectroscopy. Protein expression
was induced by the addition of 2 mM IPTG to the culture for
a period of 3 h.
2.3. Puriﬁcation of the cbEGF7–9 triplet
Bacteria were pelleted by centrifugation, then suspended
in 50 ml of 6 M guanidine–HCl, 50 mM sodium phosphate,
pH 6, 5 mM 2-mercaptoethanol (lysis buffer) and incubated
for 2 h at room temperature. Insoluble material was removed
by centrifugation at 100,000 × g for 1 h and the supernatant
was loaded onto a nickel-sepharose column (Pharmacia).
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After washing once with lysis buffer, protein was eluted from
the column in lysis buffer containing 20 mM EDTA. The elu-
ate was adjusted to 0.1 mM DTT and 0.1 M Tris–HCl, pH 8.3,
incubated for 2 h at room temperature then dialysed overnight
against 50 mM Tris–HCl, pH 8.3. After dialysis, the buffer
was acidified to pH 3 and the protein was further purified by
reverse-phase (RP)-HPLC as previously described [11]. The
protein was then lyophilised and suspended at 2 mg ml−1 in
an in vitro refolding buffer consisting of 50 mM Tris, pH 8.3,
3 mM l-cysteine, 0.3 mM l-cystine and incubated for 72 h
at 4 ◦C. The refolded protein was re-purified by RP-HPLC,
lyophilised, then suspended in 50 mM Tris–HCl, pH 7.5,
100 mM NaCl, 1 mM CaCl2 and digested with bovine fac-
tor X (Amersham Pharmacia) overnight at 37 ◦C at a 1:1000
enzyme to protein ratio by weight to remove the (His)6 tag.
The cleaved cbEGF7–9 was purified over a MonoQ column
(Pharmacia) using a gradient of 0–0.5 M NaCl in 50 mM
Tris–HCl, pH 7.3 and subjected to a final round of RP-HPLC.
The concentration of cbEGF7–9 was calculated from its theo-
retical molar extinction coefficient and absorbance at 280 nm
wavelength.
2.4. Circular dichroism
Recombinant cbEGF7–9 was suspended at 0.6 mg ml−1 in
20 mM Tris–HCl, pH 7.5 containing CaCl2 at 1 mM, 250M,
62M or 7M or containing 10 mM EGTA. Circular dichro-
ism spectra were recorded from 260 to 190 nm by use of a
Jasco J-710 spectropolarimeter. A cell of pathlength 0.2 mm
was used and all spectra were acquired at room temperature.
The final CD spectra represent the sum of 20 individual scans.
Control samples included cbEGF7–9 in 20 mM Tris–HCl, pH
7.5 without added CaCl2. CD spectra of all buffers were
recorded and subtracted from the final spectra of the triplet.
2.5. Protease digestions
Recombinant cbEGF7–9 was suspended at 0.5 mg ml−1 in
100 mM NaCl, 50 mM Tris–HCl, pH 8 supplemented with
1 mM CaCl2, 1 mM MgCl2 or 10 mM EGTA and samples
were incubated at room temperature for 30 min to equilibrate.
Enzymes were added to samples at a 1:4 (elastase) or 1:12
(trypsin or chymotrypsin) enzyme to protein ratio by weight,
and incubated for 1 h at 37 ◦C. Digestion was terminated by
the addition of Laemmli reducing SDS-PAGE loading buffer
and heating to 95 ◦C for 5 min. All samples were analysed
by SDS-gel electrophoresis on 4–15% acrylamide gradient
gels and proteins were visualised by staining with Coomassie
brilliant blue.
2.6. Mass spectrometry
All mass spectrometry was performed by use of a Quat-
tro II tandem quadrupole instrument (Micromass UK Ltd.,
Warrington, UK) in the Proteomics Facility at IAH Comp-
ton. Samples were analysed by online HPLC–MS. Briefly,
protein samples were diluted to approximately 1 pmoll−1
in HPLC running buffer A, where buffer A was 95:5
water:acetonitrile and 0.05% trifluoroacetic acid and buffer
B was 5:95 water:acetonitrile and 0.05% trifluoracetic acid.
Approximately 20 pmol was injected onto a home made pro-
tein desalting trap and was washed with excess buffer A.
Bound components were passed to a homemade capillary
HPLC column packed with Jupiter C18 reversed phase sor-
bent (3.5m bead size, 150 A˚ pore size, column i.d. 180m,
length ∼10 cm) and were eluted with an increasing gradient
of buffer B. The eluent was passed directly to the continuous
flow nanospray source of the mass spectrometer, operating
in positive ion mode. The instrument acquired full scan mass
spectra (m/z 500–2100) every 4.5 s.
3. Results
We have studied the effects of calcium binding on a triplet
of cbEGFs derived from the microneme protein EtMIC4.
A triplet was chosen for study to ensure that the cbEGF
domains were in as near-native protein context as possible and
therefore exhibit the calcium binding properties of the intact
protein [12]. The number was limited to three because of
the difficulty of refolding, in vitro, a structure rich in disul-
phide bonds, but also to allow comparisons to be made with
other triplet EGFs that are already well characterised [13,14].
Since a large amount of protein was required, we used a bac-
terial expression system that has proven to be a powerful tool
to express and refold fragments of fibrillin-1, an extracellu-
lar matrix protein that contains 43 cbEGFs [9]. cbEGF7–9 of
EtMIC4 was selected because this triplet contains three well
conserved consensus sequences for calcium binding and also
possesses several cleavage recognition sites for the serine
proteases used during protection assays in this study.
3.1. Puriﬁcation and refolding of cbEGF7–9
Time course studies were carried out to determine the opti-
mum time for harvesting bacterial cells expressing cbEGF7–9.
At 3 h post-induction, recombinant protein expression was at
a maximum with no apparent degradation of the product (data
not shown). After denaturation in 6 M guanidine–HCl, the
protein was partially purified by metal ion chromatography.
Peak fractions were pooled, made 0.1 M with respect to DTT
in 0.1 M Tris–HCl pH 8 to reduce the protein, then acidified
and further purified by RP-HPLC chromatography (Fig. 2A).
The sample was concentrated and refolded in vitro using an
oxido-shuffling system (see materials and methods). Since
there are no previously published data about the refolding
of these particular cbEGFs, we carried out in vitro refolding
trials in the presence or absence of calcium. After refolding
in the presence of 5 mM calcium, the resulting RP-HPLC
chromatogram of the refolded oxidised protein (Fig. 2B) was
dominated by a single well-resolved peak, which eluted ear-
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Fig. 2. Purification and refolding of cbEGF7–9. After dialysis and acidification, reduced cbEGF7–9 was purified by one round of reverse phase chromatography
(A) then subjected to in vitro refolding, followed by a second round of reverse phase chromatography (B). Comparison of the elution profiles in A and B clearly
shows the dramatic tightening of the elution peak and earlier elution time that occurred after oxidation, which indicates successful refolding. After digestion
with Factor X, cbEGF7–9 was separated from the cleaved (His)6 tag by anion exchange (C), then subjected to one further round of reverse phase chromatography
(D). Samples of uncleaved and cleaved cbEGF7–9 polypeptides were examined by SDS-PAGE (E), to confirm the complete removal of the (His)6 tag.
lier than the broad peak obtained with the reduced-denatured
protein (Fig. 2A). This is similar behaviour to that observed
for cbEGF fragments from other proteins [13,14] and strongly
suggests that the oxidised protein has a more hydrophilic and
homogenous conformation, consistent with what would be
expected of native cbEGFs.
The (His)6 tag was removed by Factor Xa cleavage and
the cleaved protein separated from the tag by anion exchange
chromatography (Fig. 2C). Release of the tag was confirmed
by an observed decrease in size of the recombinant pro-
tein, as monitored by SDS-PAGE (Fig. 2E). Recombinant
cbEGF7–9 was finally concentrated by RP-HPLC (Fig. 2D)
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and lyophilised. A final yield of ∼9 mg was obtained and
the molecular mass of the oxidised protein was measured
to be 13,359.5 ± 0.18 Da by electrospray mass spectrome-
try (data not shown). This agrees well with the theoretical
mass of the polypeptide, assuming all disulphide bonds are
formed, of 13,360.38 Da. Overall, during the refolding pro-
cess cbEGF7–9 behaved in a very similar manner to other
recombinant cbEGF triplets [15,16]. Taken together, the mea-
sured molecular mass, the requirement for calcium in the
oxido-shuffling process and the observed shifts in chro-
matogram profile and SDS-PAGE migration of cbEGF7–9
under reduced and oxidised conditions suggested that the
triplet was refolded into its native form.
3.2. Calcium protects cbEGF7–9 from proteolytic
digestion
To evaluate whether the putative calcium binding EGF
repeats indeed bound calcium ions, we investigated the sus-
ceptibility of refolded cbEGF7–9 to several classes of ser-
ine proteinase that are present in the intestinal lumen or
potentially associated with inflammatory processes during
E. tenella infection. Previous studies have demonstrated
that calcium binding to cbEGFs domains affords protection
against proteolysis [17,18]. In the presence of 1 mM cal-
cium, cbEGF7–9 was partially protected against digestion
by trypsin, chymotrypsin and elastase, whereas in the pres-
ence of 10 mM EGTA, substantial degradation of cbEGF7–9
occurred within 20 min (Fig. 3A–C). Resistance to proteol-
ysis was attributable to calcium binding to the protein since
the inclusion of 1 mM MgCl2 in the tryptic digestion buffers
gave very little protection (compare Fig. 3D with 3A). This
is consistent with the behaviour of other well characterised
cbEGF modules, such as those from fibrillin [19]. Protection
against trypsin digestion is particularly significant since the
activity of this enzyme is enhanced by calcium [20].
Protected cleavage sites within cbEGF7–9 were investi-
gated in detail by mass spectrometry to determine whether
specific areas of the polypeptide were particularly protected
against digestion. Tryptic cleavages sites can be clearly
defined, since this enzyme has a well characterised specificity
(trypsin cleaves C-terminal to lysine and arginine residues
unless they are followed by a proline residue). Our triplet
contains five susceptible tryptic cleavage sites: Lys9, Arg18,
Lys34, Lys90 and Lys128. Fig. 4 shows the mass spectro-
metric analysis of the cbEGF prior to reduction. Under such
conditions, the molecule remains intact despite evidence of
protease activity, since it is held together by disulphide bonds.
In the absence of calcium ions, at least three cleavage events
can be detected, as evidenced by sequential increases of
∼18 Da, caused by addition of H and OH at either side of
the cleaved bond (Fig. 4C). This produces species of mea-
sured molecular masses 13,377, 13,393 and 13,414 Da. The
major species corresponds to protein in which two bonds have
been cleaved.
Fig. 3. Protease protection assays. Refolded cbEGF7–9 was incubated with
the serine proteinases trypsin, chymotrypsin or elastase in the presence of
calcium (1 mM, panels A–C), magnesium (1 mM, panel D) or with EGTA
(10 mM, all panels). Even after 60 min of incubation, in the presence of
calcium, intact cbEGF7–9 could be seen for all enzyme treatments indicating
that calcium protects against proteolysis. The protective effect of calcium is
specific since substitution with magnesium was not protective.
To investigate which sites were cleaved predominately
by trypsin in the absence of calcium, we reduced the disul-
phide bonds in the digested cbEGF triplet and reanalysed the
sample by mass spectrometry. We found peptides liberated
by cleavages C-terminal to residues Lys9, Arg18 and Lys34
(Fig. 5). We found no evidence for cleavage after Lys90 or
Lys128, despite the fact that these represent trypsin consen-
sus sites. These data indicate that these sites are intrinsically
protected from protease digestion even in the absence of
calcium.
In the presence of calcium, mass spectrometric analy-
sis of non-reduced protein indicated that the majority of
molecules remained uncleaved. Analysis of digested sam-
ples, treated with trypsin in the presence of calcium, also
indicated partial cleavage in the N-terminal region of the
triplet. Similar analyses of chymotrypsin and elastase treated
samples yielded data that were more problematic to inter-
pret. Chymotrypsin cleaves preferentially C-terminal to large
hydrophobic residues, but has a number of secondary cleav-
age sites. Elastase cleaves adjacent to small, uncharged amino
acids, such as alanine and valine. The cbEGF triplet has multi-
ple susceptible sites to both chymotrypsin and elastase cleav-
age and, coupled with the complexity of disulphide bonds,
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Fig. 4. Deconvoluted electrospray mass spectra of cbEGF7–9. Electrospray
mass spectra were acquired for protein in the absence of protease (A), in the
presence of protease and calcium (B) and in the presence of protease and
EGTA (C). All mass spectra were deconvoluted to convert m/z information
to a mass scale. The measured mass of the oxidised refolded polypeptide
(A) agrees well with its theoretical mass of 13360 Da, assuming all disul-
phide bonds are made. After incubating with trypsin in the presence of 1 mM
calcium (B), the majority of the polypeptide remains undigested although
some increased signals are evident to the right of the main peak correspond-
ing to sequential additions of 18 Da indicating up to two cleavages in some
molecules. After incubating with trypsin in the presence of EGTA (C), the
mass of the most abundant species is 13393.5 Da, which corresponds to pep-
tides bearing two cleavages. Also present are signals corresponding to 1 and
3 cleavages.
the location of protected cleavage sites could not be deter-
mined. However, we performed mass spectrometric analysis
of non-reduced samples, in the presence and absence of cal-
cium, after treatment with either chymotrypsin or elastase.
These data demonstrated conclusively that, in the presence
of calcium, the cbEGF triplet is significantly protected from
proteolytic digestion. In the absence of calcium, smaller pro-
teolytic fragments were generated (data not shown).
3.3. Calcium binding causes a change in conformation
of cbEGF7–9
Our results from protease protection assays suggest that
calcium confers protection against proteolysis but that certain
areas of the cbEGF triplet are inherently partially protease
resistant, even in the absence of calcium. The data also sug-
gest that calcium binding imparts significant protection to
proteases, not just in the direct region of the calcium binding
Fig. 5. Electrospray mass spectra of peptides liberated after tryptic digestion
of cbEGF7–9 in the presence of EGTA and subsequent reduction of disul-
phide bonds. Peptides were separated by online capillary HPLC and analysed
by electrospray mass spectrometry. Some peptides were of low abundance
or co-eluted with other peptides, accounting for increased numbers of peaks.
In each spectrum, relevant peaks are annotated with the peptide label and the
number of charges associated with the ion. (a) Mass spectrum of the pep-
tide spanning residues 10–18 (measured mass 1061.64 Da, calculated mass
1061.46 Da); (b) mass spectrum of peptide spanning residues 1–18 (mea-
sured mass 2022.22 Da, calculated mass 2021.88 Da); (c) mass spectrum of
peptides spanning residues 1–9 (measured mass 978.26 Da, calculated mass
978.43 Da) and residues 19–34 (measured mass 1664.08 Da, calculated mass
1663.66 Da). Other peaks within spectrum (c) correspond to fragments of
the peptide 1–9 occurring in the mass spectrometer and confirm the identity
of this peptide. The cartoon indicates tryptic cleavage sites.
site but also in regions that are distant from the binding site.
NMR studies have shown significant conformational change
in other cbEGF domains on binding calcium [21] and we
wanted to assess whether our cbEGF triplet undergoes a
conformational rearrangement on calcium binding that can
account for the increased resistance to proteases.
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Fig. 6. Far UV circular dichroism spectra of refolded cbEGF repeats in the
presence of (upwards at 200 nm) 10 mM EGTA, 7M CaCl2, 60M CaCl2,
250M CaCl2 and 1 mM CaCl2 all in 20 mM Tris pH 7.5 All CD spectra
were corrected by subtraction of spectra acquired for buffer alone and were
smoothed.
The effects of calcium ions on the global folding of
cbEGF7–9 were investigated by comparing far UV CD spec-
tra of the triplet in the presence of different concentrations of
CaCl2 at pH 7.5. CD spectra are shown in Fig. 6. In the pres-
ence of EGTA, to chelate endogenous calcium ions, the CD
spectrum has a minimum at ∼198 nm and is characteristic
of a protein in predominately random coil structure. This is
consistent with NMR determinations of other EGF domains
in the absence of calcium, which possess little secondary
structure. In the presence of increasing concentrations of cal-
cium ions the CD spectrum gradually changes; there is a blue
shift to the minimum to ∼195 nm, and an increased ellipitic-
ity at around 205 nm. A loose isodichroic point is evident
at around 197 nm. The final CD spectrum, in the presence
of 1 mM CaCl2 is difficult to interpret in terms of particular
secondary structural components, however, it is indicative of
a significantly more ordered structure. In addition, the spec-
tral changes show clearly that chelation of calcium ions alter
the conformation of the cbEGF triplet. The isodichroic point
suggests that as the levels of calcium are increased, the struc-
ture of the protein shifts from one conformation to the other
without intermediates.
4. Discussion
We have shown that cbEGFs from the EtMIC4 protein of
E. tenella are able to bind calcium and that the presence of
calcium in the environment determines their conformation.
Both CD and proteolysis analyses suggest that cbEGF7–9 and,
by inference, the extracellular region of EtMIC4 that contains
31 tandem EGFs, behaves in a manner similar to other pro-
teins containing multiple cbEGFs [22]. In the presence of
calcium, all the cbEGFs in EtMIC4 could potentially adopt
a more extended, rigid conformation and be protected from
proteolysis and even in the absence of calcium the organisa-
tion of the EGFs may confer significant structural protection
against proteases. Since the invasive stages (sporozoites and
merozoites) of E. tenella have to survive within the protease-
rich environment of the chicken intestine, the protection of a
secreted/surface-bound microneme protein against proteoly-
sis may be crucial to its function.
Measurements of cbEGFs in the presence of calcium from
the solution structure of a cbEGF dimer [7] and from rotary
shadowing electron microscopy measurements of purified
fibrillin [20] agree that a single cbEGF extends ∼2.9 nm
in length. In the absence of calcium, the molecule adopts
a wider conformation that is ∼30% shorter. Thus, in the
presence of extracellular levels of calcium (∼2 mM) the 31
EGFs of EtMIC4 could theoretically adopt a stable, extended
structure of some 100 nm in length, with only limited degrees
of flexibility in putative ‘hinge’ regions between cbEGF-EGF
junctions and putative thrombospondin type I domains at the
N- and C-termini of the extracellular domain. This would
offer a distinct advantage to EtMIC4 in interacting with
host cell ligands once it reaches the parasite surface. Some
cbEGFs have been shown directly to exhibit low-affinity
binding activity [23], so the multiple copies of cbEGFs in
EtMIC4 could serve to increase the avidity of binding of
these sequences to host ligands during invasion. Alterna-
tively, the rigidified structure of the tandem EGFs could serve
as a scaffold from which the four N-terminal TSP-1 domains
of EtMIC4 are propelled closer towards their target ligands.
Experiments are ongoing to determine the binding properties
of different regions of the EtMIC4 protein. In contrast to the
extracellular milieu, levels of calcium within the late secre-
tory pathway of apicomplexan parasites are likely to be in
the micromolar concentration range, although these have not
been directly determined. Under these conditions, the 31
EGFs of EtMIC4 may adopt a shorter, flexible, and more
compacted structure that could favour the packaging of the
protein into the constricted space of the microneme organelle.
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